Genprex, Inc. (GNPX) Financials

GNPX Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2023 16.6 million 4.3 million
June 30, 2023 15.9 million 3.9 million
March 31, 2023 23.3 million 4.8 million
Dec. 31, 2022 25.1 million 2.8 million

GNPX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -4.8 million 1.5 million
June 30, 2023 -8.1 million 1.5 million
March 31, 2023 -7.0 million 1.3 million
Dec. 31, 2022 -4.6 million 1.5 million

GNPX Net Income

No data available :(

GNPX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 11.7 million - -
June 30, 2023 10.0 million - -
March 31, 2023 18.1 million - -
Dec. 31, 2022 21.0 million - -

GNPX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 57.8 million
June 30, 2023 52.0 million
March 31, 2023 49.5 million
Dec. 31, 2022 47.1 million

GNPX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 21756 4.6 million 3.2 million -
June 30, 2023 20000 4.0 million 4.1 million -
March 31, 2023 19627 5.3 million 4.0 million -
Dec. 31, 2022 19998 3.3 million 3.5 million -

GNPX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 - 3724
June 30, 2023 - 3837
March 31, 2023 - 4016
Dec. 31, 2022 - 23.8 million

GNPX

Price: $0.72

52 week price:
0.72
55.00

Earnings Per Share: -1261.62 USD

P/E Ratio: 0.14

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 159356

Market Capitalization: 1.5 million

Links: